Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004352 (
autism
)
32,579
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Autistic disorder
is a pervasive developmental disorder manifested in the first 3 years of life by dysfunction in social interaction and communication. Many efforts have been made to explore the biologic basis of this disorder, but the etiology remains unknown. Recent publications describing upper gastrointestinal abnormalities and
ileocolitis
have focused attention on gastrointestinal function and morphology in these children. High prevalence of histologic abnormalities in the esophagus, stomach, small intestine and colon, and dysfunction of liver conjugation capacity and intestinal permeability were reported. Three surveys conducted in the United States described high prevalence of gastrointestinal symptoms in children with autistic disorder. Treatment of the digestive problems may have positive effects on their behavior.
...
PMID:Autistic disorder and gastrointestinal disease. 1235 52
Gastrointestinal symptoms are common in children with
autism
spectrum disorder (ASD). A significant proportion of children with ASD and gastrointestinal symptoms have histologic evidence of
ileocolitis
(inflammation of the terminal ileum and/or colon). We previously reported the molecular characterization of gastrointestinal biopsy tissue from ASD children with
ileocolitis
(ASD
IC+
) compared to anatomically similar inflamed tissue from typically developing children with inflammatory bowel disease (IBD; i.e. Crohn's disease or ulcerative colitis) and typically developing children with gastrointestinal symptoms but no evidence of gastrointestinal mucosal inflammation (TD
IC-
). ASD
IC+
children had a gene expression profile that, while primarily overlapping with known IBD, had distinctive differences. The present study confirms these findings and replicates this molecular characterization in a second cohort of cases (ASD
IC+
) and controls (TD
IC-
). In these two separate case/control mucosal-based cohorts, we have demonstrated overlap of 59 differentially expressed transcripts (DETs) unique to inflamed ileocolonic tissue from symptomatic ASD
IC+
children. We now report that 9 of these 59 transcripts are also differentially expressed in the peripheral blood of the second cohort of ASD
IC+
children. This set of transcripts represents a putative blood-based biomarker for ASD-associated ileocolonic inflammation.
...
PMID:A Putative Blood-Based Biomarker for Autism Spectrum Disorder-Associated Ileocolitis. 2776 57